{
    "nctId": "NCT06106711",
    "briefTitle": "The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).",
    "officialTitle": "The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 92,
    "primaryOutcomeMeasure": "Adverse events (AEs) arising during treatment and degree of toxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female gender;\n* Age \u2265 18 years;\n* Signature of consent to participate in the study and to the processing of personal data (Privacy);\n* Diagnosis of stage IV breast cancer;\n* Systemic treatment with T-DM1, T-DXD or SG as monotherapy;\n* Absence of cognitive decline, expressed by a score greater than or equal to 4 on the Six Item Screener questionnaire;\n* Good understanding of the Italian language;\n* Willingness and ability to adhere to scheduled visits, treatment plan, laboratory tests and study procedures.\n\nExclusion Criteria:\n\n* All patients who do not meet the above criteria will be excluded from the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}